SM
INO icon

Skaana Management’s Inovio Pharmaceuticals INO Stock Holding History

Skaana Management’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,779
Closed -$77K – 123
2022
Q1 		$77K Sell
1,779
-17,209
-91% -$775K 0.01% 81
2021
Q4 		$1.14M Buy
+18,988
New +$1.52M 0.18% 67

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Skaana Management's INO Position: Q2 2022 in Review

Skaana Management sold out of Inovio Pharmaceuticals (INO) in Q2 2022, closing a stake of 1,779 shares — an estimated $77K sold.

Skaana Management first reported a position in INO in Q4 2021 and held it in 2 quarters. The position peaked at $1.14M in Q4 2021. 184 funds tracked by Wall St. Rank hold INO as of Q2 2022.

  • Skaana Management reported no remaining Inovio Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Skaana Management sold 1,779 Inovio Pharmaceuticals shares in Q2 2022, an estimated $77K.
  • Skaana Management first reported a position in Inovio Pharmaceuticals in Q4 2021 and held it in 2 quarters.
  • Skaana Management's Inovio Pharmaceuticals position peaked at $1.14M in Q4 2021.
  • 184 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2022.

Based on Skaana Management's 13F filing for Q2 2022, filed 11 Aug 2022.